@FiercePharma: U.K.'s rolling out flu vax program for all kids, using AstraZeneca's spray immunization. Report | Follow @FiercePharma
> Italy's Rovati family has said "no sale" to private equity firms Avista and Clessidra, which had been negotiating for a 50% stake in their drug firm Rottapharm. Story
> European antitrust regulators charged Denmark's Lundbeck, Germany's Merck KGaA and 7 other companies with violating competition law in blocking cheap knockoffs from the market; Lundbeck denied the allegations. Report
> Strong sales of its multiple sclerosis drug Avonex fueled a profits increase at Biogen Idec ($BIIB). More
> Bayer's Xarelto bloodthinner won final approval from the U.K.'s cost-effectiveness watchdogs for use in deep vein thrombosis and pulmonary embolism. Report
> The Indian government appears to be backing away from new restrictions on foreign investment in the pharma industry. Article
> China is eyeing additional healthcare reforms after expanding services led to rapidly increasing costs, in part because of an epidemic of Western-style chronic disease. Report
> Natco Pharma is set to launch its version of the stomach-acid drug Prevacid in three to four months, its CEO said. Report
Biotech News
@FierceBiotech: Sanofi sets out to reinvent itself in Genzyme's biotech image. More | Follow @FierceBiotech
@JohnCFierce: Busy biotech investor NEA unveils $2.6B global fund--says venture money controlled by a smaller number of global players. Story | Follow @JohnCFierce
@RyanMFierce: China market may grow faster than U.S. for trials tech eClinical, but I don't see that hurting U.S. software cos. Article | Follow @RyanMFierce
> ThromboGenics jolted with safety questions on eve of FDA panel review. News
> Busy biotech investor NEA unveils $2.6B global fund. Report
> Rusnano, Domain team top up CoDa venture round with $20M. Article
> Bluebird adds $60M venture haul to finance pivotal gene therapy study. Story
@FierceMedDev: Now that SCOTUS has upheld the national health reform law, winners and losers are lining up. Slideshow | Follow @FierceMedDev
@MarkHFierce: NEA closes its massive VC fund--the 14th--with $2.6 billion in committed capital. Release | Follow @MarkHFierce
@DamianFierce: Thermo Fisher posts 9% Q2 revenue growth on strong diagnostics sales. Story | Follow @DamianFierce
> Angioplasty with nitinol stents shows promise as PAD treatment. Item
> Edwards scores Q2 growth on heart valve sales. News
Drug Delivery News
> Chiasma closes multimillion funding to support oral acromegaly trial. Story
> Trials enlist vaginal gel and ring in fight against HIV. Article
> Taking insulin could be as simple as moisturizing. News
> Microneedles deliver drugs where eyedrops can't. More
Biomarkers News
> Genetic markers pinpoint medulloblastoma as four diseases, not one. News
> Blood test could predict risk of death from hypertension. Story
> Could markers manage milk allergy? More
> Sodium in the brain marks disability in MS. Article
And Finally... Johnson & Johnson ($JNJ) is shopping around for ad agencies in a global review. Report